Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stability and transmission of hepatitis C virus in different anesthetic agents.
Behrendt P, Doerrbecker J, Riebesehl N, Wilhelm C, Ciesek S, Erichsen TJ, Steinmann J, Ott M, Manns MP, Pietschmann T, Steinmann E. Behrendt P, et al. Am J Infect Control. 2013 Oct;41(10):942-3. doi: 10.1016/j.ajic.2013.01.016. Epub 2013 Mar 22. Am J Infect Control. 2013. PMID: 23523523 No abstract available.
The impact of hepatitis E in the liver transplant setting.
Behrendt P, Steinmann E, Manns MP, Wedemeyer H. Behrendt P, et al. J Hepatol. 2014 Dec;61(6):1418-29. doi: 10.1016/j.jhep.2014.08.047. Epub 2014 Sep 6. J Hepatol. 2014. PMID: 25195557 Free article. Review.
Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.
Hedenstierna M, Weiland O, Brass A, Bankwitz D, Behrendt P, Uhnoo I, Aleman S, Cardell K, Fryden A, Norkrans G, Eilard A, Glaumann H, Pietschmann T, Sällberg M, Brenndörfer ED. Hedenstierna M, et al. Among authors: behrendt p. Aliment Pharmacol Ther. 2015 Mar;41(6):532-43. doi: 10.1111/apt.13096. Epub 2015 Jan 28. Aliment Pharmacol Ther. 2015. PMID: 25627143 Free article.
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.
Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E. Anggakusuma, et al. Among authors: behrendt p. Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28. Hepatology. 2015. PMID: 25999047
Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure.
Pfaender S, Walter S, Todt D, Behrendt P, Doerrbecker J, Wölk B, Engelmann M, Gravemann U, Seltsam A, Steinmann J, Burbelo PD, Klawonn F, Feige K, Pietschmann T, Cavalleri JV, Steinmann E. Pfaender S, et al. Among authors: behrendt p. J Gen Virol. 2015 Sep;96(9):2636-2642. doi: 10.1099/vir.0.000208. Epub 2015 Jun 3. J Gen Virol. 2015. PMID: 26041875 Free PMC article.
Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D, François C, Anggakusuma, Behrendt P, Engelmann M, Knegendorf L, Vieyres G, Wedemeyer H, Hartmann R, Pietschmann T, Duverlie G, Steinmann E. Todt D, et al. Among authors: behrendt p. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2132-9. doi: 10.1128/AAC.02427-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26787701 Free PMC article.
118 results